Does addition of N-acetyl cysteine, as an adjunct to beta-blocker therapy, decrease the incidence of postcoronary artery bypass atrial fibrillation?

Authors

Katarzyna Jabbour PharmD, BCPS, Lehigh Valley Health NetworkFollow
Ashwini Kamath Mulki MD, Lehigh Valley Health NetworkFollow
Drew Keister MD, Lehigh Valley Health NetworkFollow
Robert Motley MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2018

Published In/Presented At

Jabbour, K. Mulki, A. Keister, D. Motley, R. (2018). Does addition of N-acetyl cysteine, as an adjunct to beta-blocker therapy, decrease the incidence of postcoronary artery bypass atrial fibrillation?. Evidence-Based Practice.

Disciplines

Family Medicine

Department(s)

Department of Family Medicine, Department of Family Medicine Faculty, Department of Pharmacy, Department of Pharmacy Faculty

Document Type

Article